Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Short-term Investments: 2018-2025

Historic Short-term Investments for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $506.0 million.

  • Dr Reddys Laboratories' Short-term Investments fell 43.27% to $506.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $506.0 million, marking a year-over-year decrease of 43.27%. This contributed to the annual value of $506.0 million for FY2025, which is 43.27% down from last year.
  • As of FY2025, Dr Reddys Laboratories' Short-term Investments stood at $506.0 million, which was down 43.27% from $892.0 million recorded in FY2024.
  • Dr Reddys Laboratories' Short-term Investments' 5-year high stood at $892.0 million during FY2024, with a 5-year trough of $270.0 million in FY2021.
  • Over the past 3 years, Dr Reddys Laboratories' median Short-term Investments value was $682.0 million (recorded in 2023), while the average stood at $693.3 million.
  • Per our database at Business Quant, Dr Reddys Laboratories' Short-term Investments soared by 75.32% in 2023 and then slumped by 43.27% in 2025.
  • Dr Reddys Laboratories' Short-term Investments (Yearly) stood at $270.0 million in 2021, then skyrocketed by 44.07% to $389.0 million in 2022, then surged by 75.32% to $682.0 million in 2023, then spiked by 30.79% to $892.0 million in 2024, then tumbled by 43.27% to $506.0 million in 2025.